Background

Dr. Meskill is board certified in both neurology and sleep medicine, and he is the founder and CEO of Tricoastal Narcolepsy and Sleep Disorders Center. The "Tricoastal" moniker references his background: he completed neurology residency on the East Coast at Long Island Jewish Medical Center – where he served as chief resident, sleep fellowship on the West Coast at Stanford University, and he now practices sleep medicine and neurology on the Gulf Coast in the greater Houston, Texas area. In the sleep world, he is known for expertise in the treatment of narcolepsy, obstructive sleep apnea (OSA), and insomnia. He is published in peer-reviewed journals and texts, as well as online media. He has served as principal investigator in clinical research trials focused on narcolepsy and OSA. Additionally, he regularly serves on narcolepsy treatment advisory boards for Jazz Pharmaceuticals and Harmony Biosciences. He founded A.W.A.K.E. Greater Houston, a support group for individuals afflicted with narcolepsy and other sleep disorders that works in partnership with the Narcolepsy Network and the American Sleep Apnea Association. He has been recognized by Texas Monthly magazine as one of Texas’s Super Doctors Rising Stars (2018-20) and as a Top Doctor (2021), as well as one of Houston’s Top Doctors by H-Texas magazine (2015).

Narcolepsy and Other Disorders of Central Hypersomnia

Dr. Meskill’s professional passion is to improve the lives of patients suffering from disorders of central hypersomnia, such as narcolepsy and idiopathic hypersomnia. From 2019-20, he was the principal investigator of the Houston arm of the Pitolisant Expanded Access Clinical Evaluation (PEACE) program. During PEACE, he discovered that narcolepsy type 1 patients refractory to standard-of-care agents at that time had a 75 percent improvement in cataplexy with pitolisant treatment. Dr. Meskill was invited by Harmony Biosciences to travel to the F.D.A., and on December 12, 2019, he served as their U.S.-based clinical expert on pitolisant’s role in treating cataplexy. That meeting ultimately led to the F.D.A.’s decision to approve pitolisant (Wakix) to treat cataplexy in adults with narcolepsy.

Along with internationally renowned narcolepsy expert Dr. Kallweit, Dr. Meskill co-authored an expert opinion the treatment of narcolepsy. They called for better methods to recognizing and assessing cataplexy, rather than relying solely on quantifying events irrespective of severity or impact on quality of life.

In 2021, Dr. Meskill co-authored an analysis of randomized placebo-controlled trials using pitolisant to treat excessive daytime sleepiness and cataplexy in narcolepsy. That analysis showed a low number needed to treat for both sleepiness (3-5) and cataplexy (3-4), which supports the conclusion of robust efficacy of these agents.

Dr. Meskill twice (2019, 2021) has served as keynote speaker at the University of Texas’s Houston City-Wide Sleep Medicine Conference, where he discussed how to incorporate newer narcolepsy treatment modalities into clinical management strategies. From 2017-20, he was the Sleep Education Consortium’s (Houston) expert speaker on narcolepsy. He also was the guest lecturer for narcolepsy at the 2017 North Texas Nurse Practitioners annual continuing education conference in Dallas. In May 2022, he served as the faculty narcolepsy lecturer at the American Academy of Dental Sleep Medicine’s (AADSM) annual national meeting. In June 2023, he presented as an expert on idiopathic hypersomnia at the American Academy of Sleep Medicine’s (AASM) annual national meeting.

Obstructive Sleep Apnea (OSA) and Upper Airway Resistance Syndrome (UARS)

With Drs. Guilleminault and Arora, Dr. Meskill co-authored a meta-analysis on inspiratory flow limitation (IFL). IFL is a non-invasive measure of increased upper airway resistance during sleep, which can be utilized to diagnose upper airway resistance syndrome (UARS). Prior to utilizing nasal pressure transducer flow signal to measure IFL, patients with suspected UARS would undergo an invasive and uncomfortable procedure to have a Dobhoff feeding tube inserted intranasally and down into the mid-level of the esophagus. Called “esophageal manometry” (Pes), this tube then would remain in the esophagus for the duration of the overnight sleep study. With IFL monitoring, this no longer is necessary.

Dr. Meskill also co-authored a book chapter with Dr. Guilleminault on the increased risk of stroke in sleep disorders. In it, he noted that anywhere from 50-75 percent of individuals who have a stroke/TIA also have obstructive sleep apnea (OSA), but 80 percent of all individuals with OSA are undiagnosed. Likewise, having a stroke increases the risk of having OSA, and untreated OSA in stroke increases the four-year mortality rate by 21 percent.

From 2017-19, Dr. Meskill was the principal investigator of an investigation demonstrating that a simple physical exam maneuver could predict the likelihood of having moderate-to-severe OSA.

Over the past decade, he has been published numerous times on the Huffington Post’s Stanford Center for Sleep Sciences and Medicine sleep blog. In one instance, he challenged a New England Journal of Medicine’s results that CPAP does not prevent cardiovascular events in OSA, noting that the average CPAP use in the study was just 3.3 hours per night, invalidating the claims. In another, he advocated for Medicare reform. In two other instances, he highlighted how chronic insomnia and teeth grinding/clenching during sleep (sleep bruxism) can actually be signs of UARS. More recently, Dr. Meskill was featured in Men’s Health, where he talked about his own use of CPAP to treat sleep-disordered breathing. As he jokes with patients sometimes, “I’m not only the hair club president, but I’m also a client.”

In October 2021, Dr. Meskill presented as part of a multidisciplinary team at the International Association of Orofacial Myology’s (IAOM) annual national meeting. The team of a speech pathologist (Kristie Gatto), sleep physician (Dr. Meskill), otolaryngologist (Dr. Bret Jensen), orthodontist (Dr. John Karotkin), and general dentist (Dr. Laura Lukin) presented an OSA case study to demonstrate the need for collaborative care to maximize patient outcome.

In December 2021, Dr. Meskill served as the sleep expert at the INGAA Foundation fatigue management workshop, where he addressed OSA and occupational dangers due to worker sleepiness. In May 2022, he served as the faculty UARS lecturer at the AADSM’s annual national meeting.

Since January 2023, Dr. Meskill has been a medical reviewer for SleepApnea.org.

Training

Out of high school, Dr. Meskill received an appointment to the United States Naval Academy, but ultimately he chose to attend the University of Notre Dame, where in 2003 he received his bachelor of arts (psychology). He served as Scholastic magazine’s sports editor from 2000-03, where he unofficially is recognized as the publication’s “all-time word count leader,” owing to his extensive writing throughout his tenure. In 2001, he won recognition from the Indiana Collegiate Press Association for the best sports story. In 2002, he was inducted into Alpha Epsilon Delta, the national premedical honor society.

From 2004-08, he attended medical school at S.U.N.Y. Downstate in Brooklyn, New York. In 2008, the American Academy of Neurology awarded him the medical student prize for excellence in neurology.

Dr. Meskill completed his internal medicine internship at Westchester Medical Center. He then completed his neurology residency at the Hofstra Northwell School of Medicine -- New York's largest integrated health system -- where he served as chief resident and was chosen by his peers to give the commencement address to the graduating class.

After residency, Dr. Meskill switched coasts to continue his training at Stanford University School of Medicine's Sleep Disorders fellowship program. Founded by William Dement, MD, Ph.D., Stanford's program is recognized internationally as the birthplace of the field and is considered the world's best academic sleep program. Dr. Meskill trained under many of the most renowned innovators in sleep medicine, such as Dr. Dement, considered the father of American sleep medicine; Emmanuel Mignot, MD, Ph.D., the chairman of the program and a world authority on narcolepsy; and Christian Guilleminault, MD, one of the world's most published authors in the field of sleep and a major contributor to the discovery of the physiologic mechanisms behind obstructive sleep apnea.

Curriculum Vitae

Employment

CEO/Physician, Tricoastal Narcolepsy and Sleep Disorders Center (October 2020-Present)

Medical Reviewer, SleepApnea.org (2023-Present)

Speakers Bureau, Idorsia Pharmaceuticals (2022-2023)

Speakers Bureau, Axsome Pharmaceuticals (2022-Present)

Speakers Bureau, Harmony Biosciences (2019-Present)

Speakers Bureau, Jazz Pharmaceuticals (2018-Present)

Consultant, Axsome Pharmaceuticals (2022-Present)

Consultant, Harmony Biosciences (2019-Present)

Consultant, Jazz Pharmaceuticals (2019-Present)

Physician, Comprehensive Sleep Medicine Associates (July 2013-October 2020)

Research

Principal Investigator, Pitolisant Expanded Access Clinical Evaluation [PEACE], Houston, TX (2019-20)

Principal Investigator, Simmons Chin Press and Tongue Curl [SCPTC] study, Houston, TX (2017-19)

Principal Investigator, Evaluation of Idiopathic REM Behavior Disorder via DaT SPECT imaging, Houston, TX (2014-15)

Research Associate, Evaluation of Idiopathic REM Behavior Disorder via FDG PET imaging, Manhasset, NY and Palo Alto, CA (2011-13)

Board Certifications

Neurology - American Board of Psychiatry and Neurology

Sleep Medicine - American Board of Psychiatry and Neurology

State Licensures

Texas - 2013-Present (active)

New York - 2009-2022 (inactive)

California - 2012-2014 (inactive)

Journal/Print Publications

1. Meskill GJ, Boren P, Flores J, Patel P, Meskill SD. Real-world experience switching from twice nightly to once nightly oxybate therapy in the treatment of narcolepsy. Sleep, Volume 47, Issue Supplement_1, May 2024, Pages A274–A275.

2. Meskill SD, Flores J, Boren P, Richardson SE, Patel P, Meskill GJ. Update on observational restrospective study of the efficacy of oral appliance therapy for obstructive sleep apnea. Sleep, Volume 47, Issue Supplement_1, May 2024, Page A259.

3. Nguyen K, Amico F, Meskill GJ, Ruan CH, Meskill SD. Assessing the predictive accuracy of quantitative electroencephalography in the diagnosis of narcolepsy. Sleep, Volume 47, Issue Supplement_1, May 2024, Pages A283–A284.

4. Meskill SD, Rege R, Kincheloe K, Meskill GJ. An observational retrospective study of the efficacy of oral appliance therapy (OAT) in treating obstructive sleep apnea (OSA). Sleep, Volume 46, Issue Supplement_1, May 2023, Page A226.

5. Meskill GJ, Rege R, Meskill SD. An observational retrospective study of the prevalence of comorbid postural orthostatic tachycardia syndrome (POTS) in narcolepsy. Sleep, Volume 46, Issue Supplement_1, May 2023, Pages A257–A258.

6. Meskill GJ, Davis CW, Zarycranski D, Doliba M, Schwartz JC, Dayno JM. Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With High Burden of Narcolepsy Symptoms. Sleep, Volume 45, Issue Supplement_1, June 2022, Page A172.

7. Meskill GJ, Kallweit U, Zarycranski D, Causse C, Finance O, Ligneau X, Davis C. Pitolisant for the Treatment of Cataplexy in Adults with Narcolepsy. Expert Opinion on Orphan Drugs, published online: Jan 25, 2022.

8. Meskill GJ, Davis C, Zarycranski D, Doliba M, Schwartz JC, Dayno J. Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials. CNS Drugs,36(1),61-69.

9. Meskill GJ, Davis C, Zarycranski D, Doliba M, Schwartz JC, Dayno J. Assessment of the Clinical Benefits of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy. Sleep, Volume 44, Issue Supplement_2, May 2021, Pages A198-199.

10. Meskill GJ, Kincheloe K, Simmons JH, Meskill SD. An Easy Maneuver to Screen for Moderate-to-Severe Obstructive Sleep Apnea: the Simmons Chin Press and Tongue Curl. Sleep Science, Sleep 2021;14(0):185-188.

11. Meskill GJ. Pitolisant (Wakix) is an Effective Anti-Cataplexy Agent in Narcolepsy Type 1. Sleep, Volume 43, Issue Supplement_1, April 2020, Page A287.

12. Meskill GJ, Meskill SD. Analysis Of The Effect On Blood Pressure And Heart Rate When Adding Solriamfetol (Sunosi) To Stimulant Therapy. Sleep, Volume 43, Issue Supplement_1, April 2020, Page A291.

13. Simmons JH, Meskill GJ, Lavender MG. Violent Parasomnias In Patients With REM Without Atonia. Parasomnia Overlap Disorder Vs Pure Rem Behavior Disorder. Sleep, Volume 43, Issue Supplement_1, April 2020, Page A310.

14. Meskill GJ, Kicheloe K, Simmons JH, Meskill SD. Simmons Chin Press and Tongue Curl (SCPTC) Maneuver is a Reproducible Objective Physical Exam Finding to Screen for Obstructive Sleep Apnea (OSA) Associated with Cardiovascular Morbidities and All-Cause Mortality. Sleep, Volume 42, Issue supplement_1, 12 April 2019, Pages A181-182.

15. Meskill GJ, Simmons JH, Meskill SD. Asymmetric And/or Atypical Dosing of Sodium Oxybate May Lead to Increased Compliance and Efficacy. Sleep, Volume 42, Issue Supplement_1, April 2019, Page A241.

16. Meskill GJ, Simmons JH. Patients Whose Multiple Sleep Latency Tests (MSLTs) Have Fewer Than Two Sleep-onset Rem Periods (soremps) Respond Well to Sodium Oxybate. Sleep, Volume 42, Issue Supplement_1, April 2019, Pages A241–A242.

17. Simmons JH, Ali M, Meskill GJ. Sleep Bruxism Protects the Airway. Sleep, Volume 42, Issue Supplement_1, April 2019, Page A178.

18. Meskill GJ, Kicheloe K, Simmons JH, Meskill SD. Simmons Chin Press and Tongue Curl (SCPTC) Maneuver is a Reproducible Objective Physical Exam Finding to Screen for Obstructive Sleep Apnea (OSA) Associated with Cardiovascular Morbidities and All-Cause Mortality. Sleep, Volume 41, Issue suppl_1, 27 April 2018, Page A187.

19. Simmons JH, Meskill GJ. Full Facemask Induced Upper Airway Obstruction During PAP Titrations: A Common Phenomenon Hindering PAP Treatment When Unrecognized and Indication for Combination Therapy with Oral Appliance Mandibular Stabilization. Sleep, Volume 41, Issue suppl_1, 27 April 2018, Page A198.

20. Meskill GJ, Simmons JH, Legan A, Weiss T, Bastida A, Peters BR. Are We Underselling Positive Airway Pressure (PAP) Compliance and Confounding Sleep Research? Large Multi-Center Analysis Shows PAP Compliance Data That Is Much Higher Than Previously Reported. Sleep, Volume 40, Issue suppl_1, 28 April 2017, Pages A197–A198.

21. Simmons, JH, Meskill GJ. Routine Utilization of Esophageal Pressure Monitoring (Pes) Can Be Done Reliably with Good Patient Acceptance and Can Enhance The Quality Of Care for Sleep Centers Committed to Gain the Necessary Experience. Sleep, Volume 40, Issue suppl_1, 28 April 2017, Page A232.

22. Meskill GJ, Guilleminault C. Sleep and Stroke. In: Miglis MG, ed. Sleep and Neurologic Disease. San Diego: Academic Press, 2017: 115-127.

23. Meskill GJ, Simmons JH. Analysis of Polysomnogram Data Demonstrates that Home Sleep Testing has Poor Diagnostic Sensitivity in Certain Patient Populations. Sleep, Volume 39, Issue Abstract Supplement, 2016, Page A126.

24. Simmons JH, Meskill GJ, White M, Ty S. Outcome Data Support the 2012 AASM Scoring Criteria of Hypopneas in the Absence of SaO2 Desaturation (Rule 1A). It is Unjustified to Withhold Treatment from Patients Who Do Not Desaturate. Sleep, Volume 39, Issue Abstract Supplement, 2016, Page A131.

25. Arora N, Meskill G, Guilleminault C. The role of flow limitation as an important diagnostic tool and clinical finding in mild sleep-disordered breathing. Sleep Science 2015;8(3):134-142.

26. Meskill GJ, Simmons JH. The use of DaTscan in idiopathic REM Sleep Behavior Disorder (iRBD) as a screening tool to identify patients at risk for developing parkinsonism syndromes (PS). Sleep, Volume 38, Issue Abstract Supplement, 2015, Page A281.
    

Online Publications

1. Floyd L, Meskill GJ. A Sleep Doctor Shared Exactly How He Treats His Sleep Apnea. Men’s Health, November 5, 2020.

2. Meskill GJ. CPAP Doesn’t Prevent Cardiovascular Events in Sleep Apnea, According to the NEJM, But Can That Be True? The Huffington Post, September 2, 2016.

3. Meskill GJ. Medicare Regulations Are Driving a Wedge Between Obstructive Sleep Apnea Patients and Their Providers. The Huffington Post, January 11, 2016.

4. Meskill GJ. Chronic Pain and Poor Sleep: A Vicious Cycle. Community Pain Center. May 11, 2015.

5. Meskill GJ. Stealthy Insomnia Cause? Upper Airway Resistance Syndrome Subtly Disturbs Breathing in Sleep. The Huffington Post, February 13, 2015.

6. Meskill GJ. Is Fibromyalgia a Myth? No, But it Just Might Be a Sleep Disorder. The Huffington Post, February 9, 2014.

7. Meskill GJ. Nocturnal Teeth Grinding May Suggest a Sleep Disorder. The Huffington Post, October 24, 2013.

8. Meskill GJ. Episodic Excessive Sleepiness in Teens May Represent Kleine-Levin Syndrome. The Huffington Post, April 9, 2013.

Presentations

1. Meskill GJ. Patient and Clinician Perspectives: the Multisymptom Nature of Idiopathic Hypersomnia. American Academy of Sleep Medicine (AASM) annual meeting, Indianapolis, Indiana, June 2023.

2. Meskill GJ. Upper Airway Resistance Syndrome (UARS) and Narcolepsy: Conditions of Excessive Daytime Sleepiness That Pose Diagnostic Challenges. American Academy of Dental Sleep Medicine (AADSM) annual meeting, Dallas, Texas, May 2022.

3. Meskill GJ. “Sleep Disorders: Identifying and Addressing the Dangers of Sleepiness.” INGAA Foundation Fatigue Management Workshop, December 2021.

4. Gatto, K, Meskill GJ, Lukin L, Karotkin, J. “Collaboration for Complex Care: Working Together to Make an Impact.” IAOM Conference, Virtual, October 2021.

5. Meskill GJ. “Managing Narcolepsy: Integrating New Therapies into Treatment Strategy.” Houston City-Wide Sleep Medicine Conference, University of Texas Department of Sleep Medicine, Houston, Texas, March 2021.

6. Meskill GJ. “Narcolepsy and Other Disorders of Hypersomnolence.” Sleep Education Consortium, Houston, Texas. Presented October 2017, October 2018, and January 2020.

7. Meskill GJ. “Things That Go Bump in the Night: Parasomnia and its Association with Other Conditions.” Sleep Education Consortium, Houston, Texas. Presented March 2015, April 2016, October 2017, October 2018, and January 2020.

8. Meskill GJ. “Ethical Issues, Special Considerations, and the Responsibility of Healthcare Professionals with Patients with Sleep Disorders.” Sleep Education Consortium, Houston, Texas. Presented October 2017, October 2018, and January 2020.

9. Meskill GJ. “Narcolepsy in 2019: Integrating New Therapies into Treatment Strategy.” Houston City-Wide Sleep Medicine Conference, University of Texas Department of Sleep Medicine, Houston, Texas, September 2019.

10. Meskill GJ. “Using Telemedicine to Assist in the Assessment and Management of Patients with Sleep Disorders.” Sleep Education Consortium, Houston, Texas. Presented October 2017 and October 2018.

11. Meskill GJ. “Pharmacology in the Treatment of Insomnia.” North Texas Nurse Practitioners Annual Continuing Education Conference, Dallas, Texas, April 2017.

12. Meskill GJ. “Pharmacology in the Treatment of Restless Legs Syndrome.” North Texas Nurse Practitioners Annual Continuing Education Conference, Dallas, Texas, April 2017.

13. Meskill GJ. “Living the Dream: Narcolepsy and Other Disorders of REM Sleep.” North Texas Nurse Practitioners Annual Continuing Education Conference, Dallas, Texas, April 2017.

14. Meskill GJ. “Let Me Sleep on It: How We Decide Which Sleep Test to Use.” North Texas Nurse Practitioners Annual Continuing Education Conference, Dallas, Texas, April 2017.

15. Meskill GJ. “Sleep Health Status in the U.S. Responsibilities of the Healthcare Community to Respond.” Sleep Education Consortium, Houston, Texas, April 2016.

16. Simmons JH, Meskill GJ. “Some Common Sleep Disorders That Can Affect Work and Job Performance.” UBS lunch education lecture. Houston, Texas, March 2016.

17. Chambers, J, Simmons, JH, Meskill GJ. “Houston and Beyond – Sleep Disorders.” Houston and Beyond, 1070 AM (Houston, TX) radio show. November 22, 2015.

18. Meskill GJ. “Nuances of Polysomnography in the Diagnosis and Treatment of Obstructive Sleep Apnea.” A.W.A.K.E. Greater Houston Sleep Disorders Support Group, Sugar Land, Texas, May 2015.

19. Meskill GJ. “Insomnia: Sleep Disorders Confused for Insomnia or That Make Insomnia Worse.” A.W.A.K.E. Greater Houston Sleep Disorders Support Group, Sugar Land, Texas, February 2015.

20. Meskill GJ. “Sleep Deprivation, Shift Work, and Shift Work Disorder.” Texas Children’s Hospital Department of Pediatric Emergency Medicine, January 2015.

21. Meskill GJ. “Use of Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea and the Upper Airway Resistance Syndrome.” A.W.A.K.E. Greater Houston Sleep Disorders Support Group, Sugar Land, Texas, August 2014.

22. Meskill GJ. “When Sleep Won’t Come – A Talk About Insomnia.” Stanford A.W.A.K.E. Support Group, Stanford Hospital and Clinics Department of Sleep Medicine, Redwood City, California, January 2013.

23. Meskill GJ. “Kleine-Levin Syndrome.” Stanford Hospital and Clinics Department of Sleep Medicine, Redwood City, California, January 2013.

24. Belisova Z, Meskill GJ, Osias J, and Fleming M. “Neurologic Manifestations of HIV.” Hofstra North Shore/Long Island Jewish School of Medicine, New Hyde Park, New York, May 2012.

25. Meskill GJ. “High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis: Experience of the Optic Neuritis Treatment Trial.” Hofstra North Shore/Long Island Jewish School of Medicine, New Hyde Park, New York, March 2012.

26. Belisova Z, Meskill GJ, Osias J, and Fleming M. “The Facial Nerve and the Blink Reflex.” Hofstra North Shore/Long Island Jewish School of Medicine, New Hyde Park, New York, March 2012.

27. Meskill GJ. “Visual Pathways.” Hofstra North Shore/Long Island Jewish School of Medicine, New Hyde Park, New York, August 2011.

28. Meskill GJ. “Anti-Epileptic Drugs.” Hofstra North Shore/Long Island Jewish School of Medicine, Manhasset, New York, April 2011.

29. Meskill GJ. “Anti-Epileptic Drugs for Board Review.” Hofstra North Shore/Long Island Jewish School of Medicine, Manhasset, New York, April 2011.

30. Meskill GJ, Oller-Cramsie M: North Shore/Long Island Jewish Adult Neurology Grand Rounds Presentation, “Morbidity and Mortality Conference.” Hofstra North Shore/Long Island Jewish School of Medicine, Manhasset, New York, January 2011.

31. Meskill GJ. “Psychopharmacology.” Hofstra North Shore/Long Island Jewish School of Medicine, New Hyde Park, New York, November 2010.

32. Meskill GJ, Natanzon C: North Shore/Long Island Jewish Adult Neurology Grand Rounds Presentation, “Morbidity and Mortality Conference.” Hofstra North Shore/Long Island Jewish School of Medicine, Manhasset, New York, November 2010.

33. Meskill GJ. “Psychiatry for the Neurology Boards.” Hofstra North Shore/Long Island Jewish School of Medicine, Manhasset, New York, May 2010.

34. Meskill GJ. “Electromyography Board Review.” Hofstra North Shore/Long Island Jewish School of Medicine, Manhasset, New York, April 2010.

35. Meskill GJ. North Shore/Long Island Jewish Adult Neurology Grand Rounds Presentation, “Clinical Case Presentation.” Hofstra North Shore/Long Island Jewish School of Medicine, Manhasset, New York, April 2010.

36. Meskill GJ. “Pediatric Brain Tumors.” Hofstra North Shore/Long Island Jewish School of Medicine, New Hyde Park, New York, January 2010.

37. Meskill GJ. “Lesions of the Peripheral Nervous System.” Hofstra North Shore/Long Island Jewish School of Medicine, New Hyde Park, New York, October 2009.

Honors & Awards

• Top Doctors, Texas Magazine (2021-24)

• Texas Super Doctors Rising Stars, Texas Monthly magazine (2018-22)

• Fellow of the American Academy of Sleep Medicine (2018-Present)

• Named organizer of the annual Stanford sleep medicine alumni program by Dr. Christian Guilleminault (2018-present)

• Houston’s Top Doctors, H-Texas Magazine (2015)

• Northwell neurology residency commencement speaker (2013)

• Chief resident in neurology (2012-13)

• American Academy of Neurology Medical Student Prize for Excellence in Neurology (2008)

• Alpha Epsilon Delta inductee - national premedical honor society (2002)

• Indiana Collegiate Press Association – First Place, Best Sports Story (2001)

• Indiana Collegiate Press Association – Second Place, Best Sports Story (2001, 2002)

• Columbia Scholastic Press Association Gold Circle Award, Sports News (2000)

• Appointment to the United States Naval Academy (1999)

• Athletic Director’s Award (1999)

• National Honor Society (1998-99)

Last updated: June 2024